| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| UNITUniti Group Inc. | $2.42B | 3.7× | $2.23B | +91.5% | $1.3B | $608.9M | $10.65B | AI pending |
| PBHPrestige Consumer Healthcare Inc. | $2.41B | 14.3× | $1.09B | -4.3% | $190.3M | $89.13M | $2.02B | AI pending |
| PAYOPayoneer Global Inc. | $2.41B | 51.3× | $813.41M | +14.5% | $73.19M | $346.32M | $14.43M | AI pending |
| OCULOcular Therapeutix, Inc | $2.4B | — | $51.95M | -18.5% | -$265.94M | $598.64M | $18M | AI pending |
| KODKodiak Sciences Inc. | $2.4B | — | — | — | — | $125.9M | — | AI pending |
| ALMRAlamar Biosciences, Inc. | $2.4B | — | $74.21M | +195.2% | -$29.15M | $132.97M | — | AI pending |
| GRDNGuardian Pharmacy Services, Inc. | $2.4B | 36.6× | $1.45B | +17.9% | $49.22M | $89.81M | $0 | AI pending |
| BHCBausch Health Companies Inc. | $2.4B | — | $10.27B | +6.7% | $157M | $1.83B | $20.74B | AI pending |
| CCChemours Co | $2.4B | — | $5.81B | +0.4% | -$386M | $671M | $3.87B | AI pending |
| PAGSPagSeguro Digital Ltd. | $2.39B | 6.1× | R$18.81B | +17.9% | R$2.12B | R$927.67M | R$4.52B | AI pending |
| SFBSServisFirst Bancshares, Inc. | $2.39B | 14.8× | $562.43M | +16.8% | $276.6M | $1.46B | — | AI pending |
| UFPTUfp Technologies Inc | $2.39B | 33.2× | $602.8M | +19.5% | $68.31M | $9.05M | $117.31M | AI pending |
| VOYGVoyager Technologies, Inc. | $2.38B | — | $166.42M | +15.4% | -$104.81M | $373.44M | — | AI pending |
| PTONPeloton Interactive, Inc. | $2.38B | 49.2× | $2.45B | -1.8% | $63.2M | $1.21B | $1.33B | AI pending |
| COTYCoty Inc. | $2.37B | — | $5.81B | -1.5% | -$604.8M | $176.1M | $3.05B | AI pending |
| FLYWFlywire Corp | $2.37B | 73.9× | $623.03M | +26.6% | $13.5M | $282.39M | $0 | AI pending |
| INTRInter & Co, Inc. | $2.37B | 8.3× | R$6.4B | +34.7% | R$907.13M | R$1.11B | — | AI pending |
| DBDDIEBOLD NIXDORF, Inc | $2.36B | 22.8× | $3.81B | +1.5% | $94.6M | $282.4M | $942.9M | AI pending |
| TRNTrinity Industries Inc | $2.36B | 7.1× | $2.16B | -30.0% | $253.1M | $155.7M | — | AI pending |
| VERAVera Therapeutics, Inc. | $2.33B | — | — | — | — | $48.88M | $75.23M | AI pending |